The estimated Net Worth of Jennifer Streeter is at least $300 Mille dollars as of 18 August 2022. Ms Streeter owns over 50,000 units of Perspective Therapeutics Inc stock worth over $33,769 and over the last 7 years she sold ISR stock worth over $0. In addition, she makes $266,349 as COO & VP of HR at Perspective Therapeutics Inc.
Sign up
Ms Streeter ISR stock SEC Form 4 insiders trading
Ms has made over 2 trades of the Perspective Therapeutics Inc stock since 2022, according to the Form 4 filled with the SEC. Most recently she exercised 50,000 units of ISR stock worth $21,500 on 18 August 2022.
The largest trade she's ever made was exercising 50,000 units of Perspective Therapeutics Inc stock on 18 August 2022 worth over $21,500. On average, Ms trades about 9,063 units every 2 days since 2017. As of 18 August 2022 she still owns at least 87,940 units of Perspective Therapeutics Inc stock.
You can see the complete history of Ms Streeter stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Ms. Jennifer Streeter biography
Jennifer Streeter is the COO & VP of HR at Perspective Therapeutics Inc.
What is the salary of Ms Streeter?
As the COO & VP of HR of Perspective Therapeutics Inc, the total compensation of Ms Streeter at Perspective Therapeutics Inc is $266,349. There are 5 executives at Perspective Therapeutics Inc getting paid more, with Lori Woods having the highest compensation of $416,524.
How old is Ms Streeter?
Ms Streeter is 51, she's been the COO & VP of HR of Perspective Therapeutics Inc since . There are 9 older and 7 younger executives at Perspective Therapeutics Inc. The oldest executive at Perspective Therapeutics Inc is Philip Vitale, 73, who is the Independent Director.
What's Ms Streeter's mailing address?
Jennifer's mailing address filed with the SEC is 350 HILLS STREET SUITE 106, , RICHLAND, WA, 99354.
Insiders trading at Perspective Therapeutics Inc
Over the last 18 years, insiders at Perspective Therapeutics Inc have traded over $0 worth of Perspective Therapeutics Inc stock and bought 1,651,741 units worth $855,397 . The most active insiders traders include Lori A Woods, Thomas C Lavoy e Dwight William Babcock. On average, Perspective Therapeutics Inc executives and independent directors trade stock every 60 days with the average trade being worth of $14,501. The most recent stock trade was executed by Lori A Woods on 13 April 2023, trading 187,500 units of ISR stock currently worth $114,375.
What does Perspective Therapeutics Inc do?
Isoray, Inc., through its subsidiary, Isoray Medical, Inc., is the sole producer of Cesium Blu brachytherapy seeds, which are expanding brachytherapy treatment options throughout the body.
What does Perspective Therapeutics Inc's logo look like?
Complete history of Ms Streeter stock trades at Perspective Therapeutics Inc
Perspective Therapeutics Inc executives and stock owners
Perspective Therapeutics Inc executives and other stock owners filed with the SEC include:
-
Lori Woods,
Chief Executive Officer, Director -
Lori A. Holmes-Woods,
CEO & Director -
Michael Krachon,
Executive Vice President of Sales and Marketing -
William Cavanagh,
Chief Research and Development Officer -
Michael L. Krachon,
Exec. VP of Sales & Marketing -
Jennifer Streeter,
COO & VP of HR -
William A. Cavanagh III,
Chief R&D Officer -
Krista Cline,
Senior Director of Operations, Corporate Secretary -
Philip Vitale,
Independent Director -
Alan Hoffmann,
Independent Director -
Jonathan Hunt,
Chief Financial Officer, Co-Principal Financial Officer -
Mark Austin,
Controller, Co-Principal Financial and Principal Accounting Officer -
Jennifer Streeter,
Chief Operating Officer, Vice President of Human Resources -
Michael McCormick,
Independent Chairman of the Board -
Krista Cline,
Sr. Director of Operations & Corp. Sec. -
Mark J. Austin CPA,
VP of Fin., Controller, Co-Principal Financial, Principal Accounting Officer & Sec. -
Jonathan R. Hunt,
CFO & Co-Principal Financial Officer -
Frank Morich,
Director -
Brien Ragle,
Controller -
Dwight William Babcock,
CEO -
Matthew Branson,
Principal Fin & Acct Officer -
Robert F Iii Williamson,
Director -
Thomas C Lavoy,
Director -
Albert Louis Smith,
Director -
Roger Girard,
CEO/President -
Robert R Kauffman,
Director -
Fredric Swindler,
Vice President -
David Swanberg,
EVP Operations & Secretary -
Stephen Boatwright,
Director